Detection of free antielastin antibodies among diabetic children

George Nicoloff1, Alexander Blazhev, Chaika Petrova

  • 1Departments of Biology and Pathological Physiology, University School of Medicine, Pleven, Bulgaria. nicoloff_bg@yahoo.com

Insights

Elevated free antielastin antibodies (AEAbs) are linked to vascular complications in diabetic children. Higher AEAb levels correlate with increased blood pressure and adverse lipid profiles in these patients.

Area of Science:

  • Immunology
  • Endocrinology
  • Pediatrics

Background:

  • Circulating immune complexes (CICs) form due to antibodies to elastin breakdown products (AEAbs) and their antigens.
  • Previous studies show AEAbs are present in all humans and correlate with serum peptide levels.
  • The role of free AEAbs in diabetic vascular complications is not well understood.

Purpose of the Study:

  • To investigate the correlation between serum levels of free antielastin antibodies (AEAbs) and vascular complications in diabetic children.
  • To compare free AEAb levels in diabetic children with and without vascular complications against healthy controls.

Main Methods:

  • Serum samples from 54 diabetic children and 20 healthy controls were analyzed.
  • A combination of complement inhibition factor (CIF)-ELISA and AEAb-ELISA was used to detect free immunoglobulin G (IgG) AEAbs.
  • Correlation analysis was performed between free AEAb levels and various clinical parameters, including blood pressure, lipids, and microalbuminuria.

Main Results:

  • Diabetic children exhibited significantly higher levels of free AEAbs compared to healthy controls (p = .02).
  • Children with vascular complications showed higher free AEAb levels than those without complications and controls (p = .016).
  • Free AEAb levels in diabetics correlated with systolic and diastolic blood pressure, total cholesterol, triglycerides, HDL, serum fructose, and microalbuminuria.

Conclusions:

  • Elevated serum levels of free IgG AEAbs are associated with the presence of vascular complications in diabetic children.
  • Free AEAbs may play a role in the pathogenesis of vascular complications in pediatric diabetes.
  • Further research is warranted to explore the therapeutic implications of targeting AEAbs in diabetic vascular disease.